A detailed history of Vanguard Group Inc transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 12,229,055 shares of ARWR stock, worth $240 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,229,055
Previous 12,214,101 0.12%
Holding current value
$240 Million
Previous $317 Million 25.42%
% of portfolio
0.0%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$19.36 - $29.54 $289,509 - $441,741
14,954 Added 0.12%
12,229,055 $237 Million
Q2 2024

Aug 13, 2024

SELL
$21.87 - $28.24 $4.15 Million - $5.36 Million
-189,949 Reduced 1.53%
12,214,101 $317 Million
Q1 2024

May 10, 2024

BUY
$27.21 - $39.48 $47.1 Million - $68.4 Million
1,731,974 Added 16.23%
12,404,050 $355 Million
Q4 2023

Feb 14, 2024

SELL
$21.2 - $31.03 $3.95 Million - $5.78 Million
-186,239 Reduced 1.72%
10,672,076 $327 Million
Q3 2023

Nov 14, 2023

SELL
$26.2 - $36.08 $2.97 Million - $4.09 Million
-113,415 Reduced 1.03%
10,858,315 $292 Million
Q2 2023

Aug 14, 2023

BUY
$25.16 - $41.38 $7.14 Million - $11.7 Million
283,859 Added 2.66%
10,971,730 $391 Million
Q1 2023

May 15, 2023

BUY
$23.68 - $38.51 $9.51 Million - $15.5 Million
401,699 Added 3.91%
10,687,871 $271 Million
Q4 2022

Feb 10, 2023

BUY
$28.0 - $40.56 $3.93 Million - $5.69 Million
140,182 Added 1.38%
10,286,172 $417 Million
Q3 2022

Nov 14, 2022

BUY
$29.63 - $48.31 $2.27 Million - $3.7 Million
76,653 Added 0.76%
10,145,990 $335 Million
Q2 2022

Aug 12, 2022

BUY
$27.79 - $50.61 $9.76 Million - $17.8 Million
351,087 Added 3.61%
10,069,337 $355 Million
Q1 2022

May 13, 2022

BUY
$39.62 - $69.97 $3.09 Million - $5.47 Million
78,107 Added 0.81%
9,718,250 $447 Million
Q4 2021

Feb 14, 2022

SELL
$58.09 - $82.51 $219,173 - $311,310
-3,773 Reduced 0.04%
9,640,143 $639 Million
Q3 2021

Nov 12, 2021

BUY
$58.38 - $84.96 $283,259 - $412,225
4,852 Added 0.05%
9,643,916 $602 Million
Q2 2021

Aug 13, 2021

BUY
$62.15 - $90.32 $599 Million - $871 Million
9,639,064 New
9,639,064 $798 Million

Others Institutions Holding ARWR

About ARROWHEAD PHARMACEUTICALS, INC.


  • Ticker ARWR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,849,000
  • Market Cap $2.08B
  • Description
  • Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...
More about ARWR
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.